Related Experiment Video
Updated: Dec 19, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.0K
Immune Modulation in Asthma: Current Concepts and Future Strategies
1Abteilung für Pneumologie/Interdisziplinäre Internistische Intensivstation, Medizinische Klinik I, Zentrum für Innere Medizin, Universitätsmedizin Rostock, Rostock, Germany, marek.lommatzsch@med.uni-rostock.de.
Summary
Asthma treatment has shifted to precision medicine, focusing on targeted immune modulation. Advances include new biologics for severe asthma, offering hope for treatment-resistant cases.
Area of Science:
- Immunology
- Pulmonology
- Pharmacology
Background:
- Asthma treatment has evolved significantly over two decades.
- The paradigm shifted from one-size-fits-all to personalized approaches targeting specific patient traits.
- Precision medicine in asthma emphasizes immune modulation for efficacy and safety.
Purpose of the Study:
- To review recent advances in immune-modulatory asthma treatments.
- To highlight the role of precision medicine in current and future asthma management.
- To discuss the impact of novel therapies on treatment-resistant asthma.
Main Methods:
- Literature review of recent advancements in asthma pharmacotherapy.
- Analysis of clinical trial data for immune-modulatory drugs.
- Synthesis of current trends in precision medicine for respiratory diseases.
Main Results:
- Significant progress in developing highly potent biologics for severe asthma.
- Approval of several targeted immune therapies has transformed severe asthma care.
- Emerging immune-modulatory strategies show promise for difficult-to-treat asthma.
Conclusions:
- Precision medicine, centered on targeted immune modulation, is revolutionizing asthma care.
- Biologics represent a major breakthrough for severe and potentially treatment-resistant asthma.
- Future innovations in immune-modulatory treatments are anticipated to improve outcomes for all asthma patients.
More Related Videos
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:20Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
908
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
908
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K
01:26Asthma-II: Pathophysiology and Classification
3.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K